Zai Lab Announces Acceptance by China’s NMPA of the BLA for Efgartigimod for Patients with Generalized Myasthenia Gravis
Efgartigimod alfa injection is the first accepted BLA submission of an FcRn antagonist for gMG…
Efgartigimod alfa injection is the first accepted BLA submission of an FcRn antagonist for gMG…
AUSTIN, Texas--(BUSINESS WIRE)--Terradepth and The Nippon Foundation-GEBCO Seabed 2030 project have announced a new partnership…
GUANGZHOU, China--(BUSINESS WIRE)--#ADC--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Organ Transplant Diagnostics Market 2021-2031 by Offering, Transplant, Application, Technology, End…
DUBLIN--(BUSINESS WIRE)--The "Middle East and Africa Ground Support Equipment Market 2022-2028" report has been added…
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Electronic Design Automation Tools Market 2021-2031 by Component, Tool Type, Deployment,…
DALLAS, US - Media OutReach - 13 July 2022 - J.Hilburn, a leading custom-made menswear…
MAHWAH, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a leading provider of…
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Options Technology, the leading Capital Markets services provider,…
Phase 3 trial demonstrated a reduction in SARS-CoV-2 viral load in high-risk COVID-19 patients by…